Zykadia 150 MG tablet 84S
Ended Awarded Last action
- Contract number
- SPE2DR26F9GQ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,584
Award facts
- Contract value 100% obligated
- $17,583.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,583.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 84 tablets of Zykadia 150 mg, a targeted cancer therapy medication used in the treatment of non-small cell lung cancer. The contract, issued on December 18, 2025, with an ultimate completion date of January 12, 2026, represents a non-competitive, competitively awarded delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems worldwide. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's substantial capacity and capability to meet complex federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F9GQ3?
SPE2DR26F9GQ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F9GQ3 worth?
The government has obligated $17,584 on SPE2DR26F9GQ3.
Is contract SPE2DR26F9GQ3 an order under another contract?
Yes. SPE2DR26F9GQ3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GQ3 competed?
The extent of competition for SPE2DR26F9GQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award